Praxis Precision Medicines Provides Vormatrigine Program Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. VZ
10. SPY

Go back to Praxis Precision Medicines Provides Vormatrigine Program Update

Raymond James sees a 'unique buying opportunity' in this stock

June 2, 2026 4:00 PM EDT

Raymond James believes the recent selloff in one biopharmaceutical companys shares has created an attractive entry point for investors, arguing that disappointment surrounding the company's vormatrigine program does not alter its core investment thesis.

In a research note, Raymond James analyst Tiago Fauth reiterated a Strong Buy rating on Praxis Precision Medicines (NASDAQ: PRAX) and maintained a Strong Buy rating despite a failed... More